Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…AMIS) and metastatic hormone-sensitive prostate cancer (mHSPC) (ARASENS). Darolutamide was commercialised in 2020.Aim and Objectives To…
…177Lu-PSMA-617 in this disease space. Finally, as patients with prostate cancer are living longer, the review focuses on understanding and mana…
…-phase development to practice-changing trials, particularly in prostate cancer and neuroendocrine tumours. 51 In prostate cancer, the phase II…
…veness of triplet therapies versus doublet therapies in de novo mHSPC, both overall and in high and low tumour burden subgroups (CHAA…
…ducted between April and December 2024. Patients diagnosed with mHSPC receiving full-dose apalutamide and followed in the outpatient …
…andard of care for newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC). The addition of radiation (RT) to the primary prostate…